
T-Cell–Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028
Ott, Patrick A., Bang, Yung-Jue, Piha-Paul, Sarina A., Razak, Albiruni R. Abdul, Bennouna, Jaafar, Soria, Jean-Charles, Rugo, Hope S., Cohen, Roger B., O’Neil, Bert H., Mehnert, Janice M., Lopez, JuanVolume:
37
Langue:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2018.78.2276
Date:
February, 2019
Fichier:
PDF, 1.12 MB
english, 2019